Amir Zarebkohan

Dr. Amir Zarebkohan

Assistant Professor, Department of Medical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
Samira MalekmohammadiSamira Malekmohammadi
Samira Malekmohammadi
NANegar Sedghi Aminabad
Negar Sedghi Aminabad
ASAmin Sabzi
Amin Sabzi
Amir ZarebkohanAmir Zarebkohan
Amir Zarebkohan
MRMehdi Razavi
Mehdi Razavi
Hajar MalekiHajar Maleki
Hajar Maleki
In recent years, smart/stimuli-responsive hydrogels have drawn tremendous attention for their varied applications, mainly in the biomedical field. These hydrogels are derived from different natural and synthetic polymers but are also composite with various organic and nano-organic fillers. The basic functions of smart hydrogels rely on their ability to change behavior; functions include mechanical, swelling, shaping, hydrophilicity, and bioactivity in response to external stimuli such as temperature, pH, magnetic field, electromagnetic radiation, and biological molecules. Depending on the final applications, smart hydrogels can be processed in different geometries and modalities to meet the complicated situations in biological media, namely, injectable hydrogels (following the sol-gel transition), colloidal nano and microgels, and three dimensional (3D) printed gel constructs. In recent decades smart hydrogels have opened a new horizon for scientists to fabricate biomimetic customized biomaterials for tissue engineering, cancer therapy, wound dressing, soft robotic actuators, and controlled release of bioactive substances/drugs. Remarkably, 4D bioprinting, a newly emerged technology/concept, aims to rationally design 3D patterned biological matrices from synthesized hydrogel-based inks with the ability to change structure under stimuli. This technology has enlarged the applicability of engineered smart hydrogels and hydrogel composites in biomedical fields. This paper aims to review stimuli-responsive hydrogels according to the kinds of external changes and t recent applications in biomedical and 4D bioprinting.

10 January 2022 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
MFMasoud Farshbaf
Masoud Farshbaf
HVHadi Valizadeh
Hadi Valizadeh
YPYunes Panahi
Yunes Panahi
Yousef FatahiYousef Fatahi
Yousef Fatahi
MCMeiwan Chen
Meiwan Chen
huile gaohuile gao
huile gao

5 July 2022 in Journal of Controlled Release
Verified
Journal Article
Closed access
YTYasamin Davatgaran Taghipour
Yasamin Davatgaran Taghipour
Amir ZarebkohanAmir Zarebkohan
Amir Zarebkohan
RSRoya Salehi
Roya Salehi
FRFariborz Rahimi
Fariborz Rahimi
VTVladimir P. Torchilin
Vladimir P. Torchilin
ASAlexander Seifalian
Alexander Seifalian

1 October 2020 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
ASAmin Sabzi
Amin Sabzi
ARAkram Rahmani
Akram Rahmani
MEMahdi Edalati
Mahdi Edalati
HKHouman Kahroba
Houman Kahroba
MDMohammad Reza Dadpour
Mohammad Reza Dadpour
Amir ZarebkohanAmir Zarebkohan
Amir Zarebkohan

20 July 2021 in Genes
Verified
Journal Article
Open access
PDF file
FGFereydoon Abedi Gaballu
Fereydoon Abedi Gaballu
William C. ChoWilliam C. Cho
William C. Cho
GDGholamreza Dehghan
Gholamreza Dehghan
Amir ZarebkohanAmir Zarebkohan
Amir Zarebkohan
Behzad BaradaranBehzad Baradaran
Behzad Baradaran
JDJafar Ezzati Nazhad Dolatabadi
Jafar Ezzati Nazhad Dolatabadi
The transcription factor high mobility group protein A2 (HMGA2) plays an important role in the pathogenesis of some cancers including breast cancer. Polyamidoamine dendrimer generation 4 is a kind of highly branched polymeric nanoparticle with surface charge and highest density peripheral groups that allow ligands or therapeutic agents to attach it, thereby facilitating target delivery. Here, methotrexate (MTX)- modified polyamidoamine dendrimer generation 4 (G4) (G4/MTX) was generated to deliver specific small interface RNA (siRNA) for suppressing HMGA2 expression and the consequent effects on folate receptor (FR) expressing human breast cancer cell lines (MCF-7, MDA-MB-231). We observed that HMGA2 siRNA was electrostatically adsorbed on the surface of the G4/MTX nanocarrier for constructing a G4/MTX-siRNA nano-complex which was verified by changing the final particle size and zeta potential. The release of MTX and siRNA from synthesized nanocomplexes was found in a time- and pH-dependent manner. We know that MTX targets FR. Interestingly, G4/MTX-siRNA demonstrates significant cellular internalization and gene silencing efficacy when compared to the control. Besides, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay demonstrated selective cell cytotoxicity depending on the folate receptor expressing in a dose-dependent manner. The gene silencing and protein downregulation of HMGA2 by G4/MTX-siRNA was observed and could significantly induce cell apoptosis in MCF-7 and MDA-MB-231 cancer cells compared to the control group. Based on the findings, we suggest that the newly developed G4/MTX-siRNA nano-complex may be a promising strategy to increase apoptosis induction through HMGA2 suppression as a therapeutic target in human breast cancer.

30 January 2023 in Cancer Letters
Verified
Journal Article
Closed access
NMNarges Mardi
Narges Mardi
FSFatemeh Salahpour-Anarjan
Fatemeh Salahpour-Anarjan
MNMahdieh Nemati
Mahdieh Nemati
NBNasim Shahsavari Baher
Nasim Shahsavari Baher
RRReza Rahbarghazi
Reza Rahbarghazi
Amir ZarebkohanAmir Zarebkohan
Amir Zarebkohan